Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The inhibitor affects androgen metabolism but not ovarian function.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

PRP is safer and has a lower relapse rate than TAC for treating alopecia areata.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Using minoxidil with tocopherol acetate in ethosomes improves hair regrowth in hair loss treatment.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

The films can help heal wounds by promoting blood vessel growth.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Upadacitinib may effectively treat alopecia areata without side effects.

Intralesional steroids effectively treated a young female's scalp nodules without recurrence.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Certain drugs change freshwater snail shells to a "banana" shape.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.